ArriVent BioPharma, Inc. (: AVBP) saw its stock dip 4.79% in the after-hours session on Tuesday, July 1, 2025, falling to $19.89 subsequent to $75 million common stock offering announcement.
ArriVent BioPharma, Inc. (AVBP) announced its plan to offer and sell $75 million of common stock. The company intends to use the net proceeds along with existing cash to advance firmonertinib and other pipeline programs. It will also allocate funds for working capital and general corporate purposes.
The stock had closed the regular trading day at $20.89, after opening at $21.63 and fluctuating between $20.68 and $22.02. Trading volume for the day reached 407.80 thousand shares.
